Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model

NeuroImage
Michael G DwyerRobert Zivadinov

Abstract

SIENA and similar techniques have demonstrated the utility of performing "direct" measurements as opposed to post-hoc comparison of cross-sectional data for the measurement of whole brain (WB) atrophy over time. However, gray matter (GM) and white matter (WM) atrophy are now widely recognized as important components of neurological disease progression, and are being actively evaluated as secondary endpoints in clinical trials. Direct measures of GM/WM change with advantages similar to SIENA have been lacking. We created a robust and easily-implemented method for direct longitudinal analysis of GM/WM atrophy, SIENAX multi-time-point (SIENAX-MTP). We built on the basic halfway-registration and mask composition components of SIENA to improve the raw output of FMRIB's FAST tissue segmentation tool. In addition, we created LFAST, a modified version of FAST incorporating a 4th dimension in its hidden Markov random field model in order to directly represent time. The method was validated by scan-rescan, simulation, comparison with SIENA, and two clinical effect size comparisons. All validation approaches demonstrated improved longitudinal precision with the proposed SIENAX-MTP method compared to SIENAX. For GM, simulation showed bette...Continue Reading

References

Jun 30, 2000·IEEE Transactions on Medical Imaging·M StynerG Gerig
May 15, 2001·Journal of Computer Assisted Tomography·S M SmithP M Matthews
Oct 23, 2002·Human Brain Mapping·Stephen M Smith
Feb 10, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Robert Zivadinov, Rohit Bakshi
Sep 29, 2004·Medical Image Analysis·Maria Lorenzo-ValdésDaniel Rueckert
Jan 24, 2006·Lancet Neurology·Robert A Bermel, Rohit Bakshi
Feb 24, 2006·Alzheimer Disease and Associated Disorders·Leon J ThalEric Siemers
May 13, 2006·IEEE Transactions on Medical Imaging·Colin StudholmeValerie Cardenas
Oct 20, 2006·Computer Methods and Programs in Biomedicine·Jeffrey SolomonArun Sood
Nov 28, 2006·NeuroImage·Valerie A CardenasDieter J Meyerhoff
Aug 19, 2007·Brain : a Journal of Neurology·Gwenaëlle DouaudAnthony James
Sep 27, 2007·Journal of Magnetic Resonance Imaging : JMRI·Bas JasperseUNKNOWN Magnetic Imaging in Multiple Sclerosis (MAGNIMS) study group
Feb 8, 2008·NeuroImage·Marco BattagliniNicola De Stefano
May 7, 2008·Neurology·J D SluimerW M van der Flier
Mar 17, 2009·Journal of the Neurological Sciences·Marco BattagliniNicola De Stefano
Apr 7, 2009·Journal of the Neurological Sciences·Robert Zivadinov, Alireza Minagar
Feb 2, 2010·NeuroImage·Shiva KeihaninejadUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 13, 2010·NeuroImage·Robin WolzUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 3, 2010·NeuroImage·Kunio NakamuraElizabeth Fisher
Dec 18, 2010·Neurobiology of Aging·Valerie M AndersonNick C Fox
Jan 5, 2011·NeuroImage·Kelvin K LeungUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 1, 2011·Medical Image Analysis·L Cordero-GrandeC Alberola-López
Jul 19, 2011·Psychiatry Research·Keith S CoverUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 8, 2011·NeuroImage·Kelvin K LeungUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Dec 14, 2011·BMC Neurology·Hanneke E Hulst, Jeroen J G Geurts
Mar 21, 2012·NeuroImage·Martin ReuterBruce Fischl

❮ Previous
Next ❯

Citations

Mar 5, 2016·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Angela Vidal-JordanaXavier Montalban
Apr 24, 2015·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T UherR Zivadinov
Nov 8, 2014·NeuroImage. Clinical·Tomas UherRobert Zivadinov
Dec 3, 2014·Journal of the Neurological Sciences·Tomas UherRobert Zivadinov
Apr 23, 2016·Expert Review of Neurotherapeutics·Robert ZivadinovNiels Bergsland
Nov 5, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Robert ZivadinovBianca Weinstock-Guttman
Nov 7, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Niels BergslandRalph Hb Benedict
Feb 18, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Robert ZivadinovDana Horakova
Aug 14, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D JakimovskiR Zivadinov
Aug 23, 2019·Annals of Clinical and Translational Neurology·Dejan JakimovskiRobert Zivadinov
Feb 26, 2020·Nature Reviews. Neurology·Jaume Sastre-GarrigaUNKNOWN MAGNIMS study group
Feb 18, 2020·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Cecilie JacobsenElisabeth Farbu
May 4, 2017·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Tomas UherRobert Zivadinov
Dec 10, 2017·Human Brain Mapping·Marco BattagliniUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 1, 2020·Fluids and Barriers of the CNS·Dejan JakimovskiMarcella Maria Lagana
Dec 3, 2020·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Dejan JakimovskiRalph H B Benedict
Dec 18, 2020·Multiple Sclerosis and Related Disorders·Franziska E HildesheimRobert Zivadinov
Feb 4, 2021·Annals of Clinical and Translational Neurology·Nicola De StefanoMarco Battaglini
Nov 27, 2020·Therapeutic Advances in Neurological Disorders·Robert ZivadinovNiels Bergsland
Dec 15, 2020·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Tomas UherManuela Vaneckova
Mar 18, 2021·Neurology. Neuroimmunology and Neuroinflammation·Tomas UherTomas Kalincik
Oct 7, 2021·Multiple Sclerosis : Clinical and Laboratory Research·Tomas UherJens Kuhle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.